Expert Review of Neurotherapeutics logo Expert Reviews logo

Expert Review of Neurotherapeutics provides expert commentary on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.

Publisher: Expert Reviews

Volume 2, Number 5, September 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Does gender play a role in Alzheimer therapy?
pp. 589-591(3)
Author: Heun, Reinhard

Miscellaneous

News in Brief
pp. 592-600(9)

Drug Evaluation

Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms
pp. 601-608(8)
Author: Kampman, Kyle M

Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin
pp. 609-615(7)
Authors: Hau, Peter; Dietrich, Joerg; Fabel, Klaus; Bogdahn, Ulrich

Nefazodone in the treatment of patients with post-traumatic stress disorder
pp. 617-623(7)
Authors: Sharpe, Rachel H; Voris, John C

Oral transmucosal fentanyl citrate: a novel agent for breakthrough pain related to cancer
pp. 625-629(5)
Authors: McMenamin, Erin; Farrar, John T

Miscellaneous

Intrathecal steroid therapy for postherpetic neuralgia: a review
pp. 631-637(7)
Authors: Nelson, Dewey A; Landau, William M

Review

Genomics of immune molecules: early detection of cognitive decline and new therapeutic interventions
pp. 639-645(7)
Author: Licastro, Federico

Acetyl-l-carnitine as a possible therapy for Alzheimer’s disease
pp. 647-654(8)
Authors: Pettegrew, Jay W; McClure, Richard J

Pharmacotherapy of agitation and psychotic symptoms in Alzheimer’s disease
pp. 655-664(10)
Author: Verhoeff, Nicolaas PLG

Neurosyphilis: is it still a clinically relevant form of dementia?
pp. 665-668(4)
Authors: Thompson, Matthew M; Samuels, Steven C

Bristol Activities of Daily Living Scale: a critical evaluation
pp. 669-676(8)
Authors: Bucks, Romola S; Haworth, Judy

Transcriptional mechanisms underlying neuropathic pain: DREAM, transcription factors and future pain management?
pp. 677-689(13)
Authors: Cheng, Hai-Ying M; Penninger, Josef M

New pharmacological strategies for pain relief
pp. 691-702(12)
Authors: Gillen, Clemens; Maul, Corinna

Therapeutic options in neurosarcoidosis
pp. 703-708(6)
Authors: Kaliszky, Zoltan; Walker, Aljoeson; Tyor, William R

Neurobehavioral and psychological changes induced by hyperthyroidism: diagnostic and therapeutic implications
pp. 709-716(8)
Authors: Fardella, Carlos E; Gloger, Sergio

Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder
pp. 717-724(8)
Authors: Baldwin, David; Buis, Christel; Mayers, Andrew

Phenomenology and therapeutic options for dermatotillomania
pp. 725-730(6)
Author: Arnold, Lesley M

Cognitive dysfunction in multiple sclerosis: current approaches to clinical management
pp. 731-742(12)
Authors: Amato, Maria Pia; Zipoli, Valentina

Treatment of myasthenia gravis: current practice and future directions
pp. 743-748(6)
Authors: Ciafaloni, Emma; Sanders, Donald B

Behavioral treatment strategies for migraine and tension-type headache: a review of the evidence and future directions
pp. 749-760(12)
Authors: Rains, Jeanetta C; Penzien, Donald B

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A